FDA clears SurGenTec's ION-L navigation instruments for lumbar facet fixation

SurGenTec has received U.S. Food and Drug Administration 510(k) clearance for its ION-L navigation instruments, allowing the ION-L Lumbar Facet Fixation System to be used with Medtronic's StealthStation navigation platform, the company announced.

The navigation instruments are designed to help surgeons locate anatomical structures — specifically the lumbar facet joint — during open or minimally invasive spinal procedures, according to SurGenTec. The company said the addition supports implant placement and surgical workflow efficiency for posterior lumbar facet fusion procedures.

ION-L uses a zero-profile implant design paired with what SurGenTec described as controlled drill-to-implant geometry, intended to support non-impact placement and implant depth accuracy. The system is built to help maintain the facet joint in a neutral position during insertion, reducing the risk of unintended joint expansion, the company said, while supporting controlled posterior lumbar fixation and helping preserve native spinal alignment.

SurGenTec listed several potential benefits of navigated ION-L facet fixation, including precision placement during lumbar facet targeting, improved visualization of lumbar anatomy and surrounding structures, and increased procedural control. The company also said navigation compatibility may help reduce operative time, radiation exposure and procedural complications, though it characterized these as potential rather than confirmed outcomes.

Travis Greenhalgh, CEO and founder of SurGenTec, said the clearance reflects the company's broader strategy around lumbar spine disease treatment.

"Navigation compatibility for ION-L demonstrates our continued commitment to giving surgeons advanced options as they treat patients with lumbar spine disease requiring fixation," Greenhalgh said in a statement. "For years, achieving precision during posterior lumbar fixation has depended heavily on fluoroscopic guidance and surgeon experience alone. With ION-L now compatible with navigation, surgeons have another tool to support accurate, efficient placement while continuing to benefit from a less invasive approach."

Historically, posterior lumbar fixation procedures have relied on fluoroscopic imaging and surgeon experience to guide instrument and implant placement. SurGenTec said pairing ION-L with StealthStation navigation is intended to give surgeons additional real-time guidance during those procedures.

SurGenTec is a privately held medical device company focused on spine and orthopedic surgery, with a portfolio that includes facet fixation technologies, a synthetic biologics line, bone marrow aspiration kits and sacroiliac joint fixation systems. The company said it has recently expanded into international markets, including establishing an international sales headquarters in Brazil.

Navigation's growing footprint in spine surgery

The ION-L clearance arrives amid a broader push by device makers to pair fixation and instrumentation hardware with intraoperative navigation technology. Surgical navigation platforms have traditionally been associated with pedicle screw placement in fusion procedures, but device companies are increasingly extending navigation compatibility to adjacent procedures, including facet fixation, in an effort to standardize precision across more of the lumbar spine workflow.

Proponents of navigation-assisted spine surgery argue that intraoperative guidance can reduce reliance on repeated fluoroscopic imaging, potentially lowering radiation exposure for both patients and surgical teams while improving consistency in implant placement. Critics and health system administrators, meanwhile, continue to weigh those potential benefits against the capital costs and workflow changes associated with adopting navigation platforms, particularly in ambulatory surgery centers with tighter equipment budgets.

The broader minimally invasive spine fixation device market has also seen a steady stream of FDA clearances in recent months, reflecting continued competition among device makers to refine implant geometry, reduce procedural footprint and expand compatibility with existing OR navigation infrastructure. As more systems are engineered for interoperability with established platforms like StealthStation, hospitals and surgery centers may find it easier to standardize navigation use across multiple procedure types without investing in additional capital equipment.